Jun 23, 2009
1:5
For every 5 shares held, investors received 1. The price per share adjusted from $11.80 to $59.00.
The split itself did not change the total investment value.
XTL Biopharmaceuticals Ltd. (TASE:XTLB) operates in the Medical specialties industry.
XTL Biopharmaceuticals Ltd. company overviewXTL Biopharmaceuticals Ltd.'s most recent stock split was on June 23, 2009. It was a 1-for-5 reverse split, so shareholders received 1 share for every 5 they held.
XTL Biopharmaceuticals Ltd. (TASE:XTLB) has split its stock 2 times: a 38-for-37 split on July 2, 2004 and a 1-for-5 reverse split on June 23, 2009.
XTL Biopharmaceuticals Ltd. has split its stock 2 times. This history records 2 splits between July 2, 2004 and June 23, 2009.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In XTL Biopharmaceuticals Ltd.'s 1-for-5 reverse split on June 23, 2009, every 5 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
XTL Biopharmaceuticals Ltd. has not announced a new split in our records. Its most recent split was on June 23, 2009, 17 years ago. Companies announce splits in advance, and any new TASE:XTLB split will appear on this page.
Already premium?